Some of the biggest names in US food manufacturing – including Nestle, Kellogg and Unilever - have been accused of infringing patents covering fats that alter the ratio of ‘good’ and ‘bad’ cholesterol in the blood.
Direct selling giant Amway is only one of many firms making deceptive and illegal disease prevention claims about immunity, according to the Center for Science in the Public Interest (CSPI).
Many dietary supplement companies are not fully compliant with GMP regulations, putting them at risk of warning letters and more, but resources are available to help companies prepare for an FDA inspection, says the Council for Responsible Nutrition (CRN).
The US Patent and Trademark Office (USPTO) has granted a request from Aker BioMarine to re-examine another US patent recently awarded to its arch rival Neptune Technologies & Bioressources.
Fuji Health Science has received a no objections letter from the US Food and Drug Administration (FDA) responding to its new dietary ingredient (NDI) notification to up the permitted daily dosage of its AstaREAL branded astaxanthin to 12mg/day.
The Food and Drug Administration (FDA) is aiming to publish a proposed rule to reform the Nutrition Facts panel and related rules by the end of this year, somewhat later than originally expected.
Norwegian firm Calanus AS has applied to the UK Food Standards Agency for European Union novel foods approval to market an omega-3 oil derived from the miniature North Atlantic Ocean shrimp, Calanus finmarchicus.
DNP International – the latest in a string of firms to be sued by Natural Alternatives International (NAI) for patent infringement over beta-alanine - insists the patent at issue is invalid and predicts it will “ultimately be vindicated” by the courts.
GNC, Cellucor Sports Nutrition and others have been accused of misleading consumers over the source, regulatory status and safety of the controversial stimulant DMAA (1,3 Dimethylamylamine) in a new class action lawsuit filed in California.
The US Food and Drug Administration (FDA) is to investigate the safety of an inhalable caffeine shot called AeroShot, which only hit US shelves last month.
Experts in helping firms navigate the GRAS (generally recognized as safe) process say the American Heart Association (AHA) made some valid points in its recent attack on GRAS, but argue the system is actually working pretty well.
Plant sterol and stanol consumption by those like children who do not have raised cholesterol could itself lead to heart problems, the German foods safety agency has said.
POM Wonderful has come under fire again for allegedly misleading and deceiving consumers about the health benefits of its antioxidant-packed wares in a new class action lawsuit.
There are serious weaknesses in the system that allows firms to self-affirm the safety of foods without the approval or knowledge of the Food and Drug Administration (FDA), according to the American Heart Association (AHA).
Utah-based Barlow Herbal Specialties has agreed to stop making certain claims in ads about its top-selling LDM-100 supplement after an ad claims watchdog determined they were not supported by scientific evidence.
A probe into joint health supplement Instaflex by the National Advertising Division of the Council of Better Business Bureaus (NAD) has found that the health claims it makes are supported by evidence.
Food and Drug Administration (FDA) officials were “engaged” and “receptive” during a meeting with the Council for Responsible Nutrition (CRN) this week about its controversial draft guidance on new dietary ingredients (NDIs), says the CRN.
Global omega-3 EPA and DHA organization GOED is aiming to submit a petition for an authorized health claim about long chain omega-3s and coronary heart disease risk reduction by the end of the year.
A federal judge in California has given the green light to a class action lawsuit filed in 2009 alleging that healthcare giant Bayer misled shoppers by claiming its men’s vitamins could support prostate health.
A new paper published by the American Botanical Council (ABC) attempts to dispel the ‘puzzling’ and pervasive ‘myth’ that the US dietary supplements trade is unregulated.
The court handling a patent infringement lawsuit filed by Neptune Technologies and Bioressources against Aker BioMarine and Schiff Nutrition has agreed to stay (temporarily halt) proceedings until a re-examination of the krill oil patent at issue is completed.
Nutraceuticals firm VDF FutureCeuticals (VDF FC) and Hawaiian superfruit juice maker KonaRed have traded insults in a public spat over the former’s intellectual property.
Both parties in a protracted dispute over heart-healthy ingredients and intellectual property rights claim to have emerged from a new settlement with “valid and enforceable” patents covering their products.
Six online marketers accused of using ‘fake news’ sites to peddle bogus weight loss claims about acai berry supplements have agreed to settlements with the Federal Trade Commission (FTC) that will permanently halt their allegedly deceptive practices.
It might have been roundly slammed by the trade as draconian and unworkable, but according to one academic, the Food and Drug Administration’s (FDA’s) controversial draft guidance on new dietary ingredients (NDIs) does not go far enough.
The three firms that have now been hit with a patent infringement lawsuit filed by Natural Alternatives International (NAI) are not the only ones allegedly infringing NAI’s newly-granted patent regarding sports nutrition ingredient beta-alanine, claims...
An analysis of recent Food and Drug Administration (FDA) warning letters has exposed several ‘ten ton elephants in the room’ and ‘time bombs waiting to go off’ when it comes to cGMP (current good manufacturing practice) compliance, according to one leading...
A surprising numbers of companies contacted by the Natural Products Foundation (NPF) about unauthorized disease or drug claims on supplements are unaware that they are breaking the law, according to NPF executive director Deb Knowles.
Schiff Nutrition International, Aker BioMarine ASA and its US subsidiary Aker BioMarine Antarctic USA have filed a motion to stay a patent infringement lawsuit filed against them by Aker’s arch rival Neptune Technologies & Bioressources.
A class action complaint has been filed in California alleging that the maker of Lipozene weight loss supplements - which contain glucomannan from konjac root – is making false and misleading claims about their efficacy.
The firm at the center of the 2009 Hydroxycut recall has been told to pay $1.5m to settle 10 California district attorneys' complaints over deceptive advertising of its dietary supplements and Proposition 65 violations.
An increase in GRAS (generally recognized as safe) determinations for an ingredient, and particularly self-affirmed GRAS, suggests that industry is looking at the alternatives to NDI notifications, but what are the consequences?
Neptune Technologies and Bioressources has filed ‘continuation’ applications with the US Patent & Trademark Office (USPTO) it says will allow it to pursue “additional patent claims that should preclude our competitors from selling their krill oil...
Another firm has been ordered to pay a large sum to settle a case brought by the Federal Trade Commission (FTC) as part of its crackdown against firms making bogus weight loss claims about acai pills.
Trade in sports products containing the controversial stimulant DMAA (methylhexaneamine/1,3-dimethylamylamine) is illegal in the European Union, and should be brought to an immediate halt by EU and member state authorities, according to the Council for...
Staff for Senators Harkin and Hatch are still waiting for a response from the Food and Drug Administration (FDA) following calls from the Senators for FDA to withdraw its NDI draft guidance and for January meetings to discuss concerns.
USPLabs has insisted that the DMAA (1,3-Dimethylamylamine) in its Jack3d and OxyELITE Pro supplements is from geranium in the wake of continued speculation over the source and regulatory status of the popular stimulant.
US Pharmacopeia has drafted new ingredient quality standards for inclusion in the Food Chemicals Codex (FCC), for probiotics, steviol glycosides, benzoates, infant formula and flavoring ingredients, and is seeking industry comments.
Wellness International Network is forecasting a large expansion in the United States sports market following its NSF Certified for Sport program certification.
Anaheim-based GMP Laboratories of America Inc has been Certified for Sport by NSF International, as the company met stringent certification requirements, including testing for more than 150 banned substances.
The FDA published a handful of warning letters in late December, with cGMP violations and claims on websites and social media sites continuing to catch the FDA’s eye.
The US Department of Defense has temporarily banned the sale of products containing DMAA within military facilities following links to two recent soldier deaths.
Jarrow Rogovin, never a man to mince his words, says it is high time the IPA and other trade groups stepped up to the plate to defend a sector that has been under regulatory siege on both sides of the Atlantic for several years.
The US Patent and Trademark Office (USPTO) has granted Aker BioMarine's request to re-examine a krill oil patent just awarded to arch rival Neptune Technologies & Bioressources.
The Food and Drug Administration (FDA) has weighed into the debate over the stimulant DMAA (1,3-Dimethylamylamine, also known as methylhexaneamine or MHA), which has garnered more bad press in recent weeks.
Those hoping the Food and Drug Administration (FDA) is preparing for a major climb down on its draft guidance on new dietary ingredients (NDIs) will draw little comfort from comments made by the agency's supplements chief yesterday.